Engystol - 100 TB by Heel/BHI Homeopathics
Sale Price: $25.65
You Save: ()
Engystol information Engystol PDF
MGN-3 is now Noxylane 4 DS - 50 CP
Engystol - 100 TB by BHI HEEL
To activate the non-specific defensive mechanism, particularly in the case of influenza and questionable virus diseases.
Vincetoxicum 6X, Vincetoxicum 10X, Vincetoxicum 30X ana 75 mg; Sulfur 4X, Sulfur 10X ana 37.5 mg.
In general, 1 tablet dissolved under the tongue 3 times daily.
Form in which supplied and package size:
Bottle containing 100 tablets.
Pharmacological and clinical notes
Vincetoxicum (swallowwort) Stimulation of the body's own defenses with vascular and sympathetic action, e.g. in feverish viral diseases such as influenza, mumps, etc.
Sulfur (sulphur) Reagent in all diseases; cellular activity is influenced catalytically.
Based on the individual homeopathic constituents of Engystol, therapeutic possibilities result for the activation of the body's own non-specific defenses, particularly in vague feverish infections and for influenza, as well as after Roentgen irradiation and generally in viral infections of all kinds, viral influenza, viral pneumonia and viral hepatitis, as well as after vaccination (against smallpox), also stomatitis aphthosa.
Many skin diseases (neurodermatitis, urticaria, pruritus simplex et vulvae, eczema, furunculosis, etc.)
Diseases of the respiratory organs (bronchitis, bronchiectasis, pertussis, pneumonia and asthma), of the heart and circulation (paroxysmal tachycardia, endocarditis) Migraine, neuralgia, causalgia.
Allergies of every kind and location (including hay fever) and various forms of rheumatism (including gout), of the kidneys, liver and central nervous system.
Experimentally in toxoplasmosis (together with Traumeel i.v.) Impregnation and degeneration phases in the form of therapeutic damage (in addition to the intermediary acids of the citric acid cycle)
Engystol exerts a generally lowering action on high homotoxin levels, especially after therapeutic damage with the presence of impregnation and possibly also degeneration phases, particularly also in virus diseases, which are characterized by the penetration of the virus (homotoxin) into the cell. Here Engystol has no direct virostatic or virocidal effect. The effect of Engystol rests, rather, on the vincetoxin which acts similarly to aconitine, and on the asclepiadic acid (constituent of Vincetoxicum officinale), with action on the vessels and sympathetic nervous system, as well as depending on colloidal sulphur, through which, by unblocking disturbed enzyme functions (sulphide enzymes), a general non-specific stimulation of the major defensive system takes place and the way is cleared for a far-reaching detoxication. Engystol, consequently, exercises (in a similar way to Lymphomyosot), also a channeling action on the whole mesenchymal, and particularly on the Iymphatic system. This forms the foundation also for the indications of Engystol for allergies, secondary diseases and sequelae (such as agranulocytosis, neuritis, impairment of the liver, kidneys, bone marrow and myocardium; nephritis, etc.)
In serious feverish reaction phases, e.g. sepsis, after Engystol occasionally, at first, there is a slight worsening lasting from 3-5 hours, followed by a compensatory curative phase.
The dosage is adjusted according to the disease, the clinical picture and the stage of the illness: 1 ampule i.v., i.m., s.c.
1-3 times weekly, possibly together with the patient's own blood. For viral diseases 1 ampule i.v. daily; for small children and infants i.m. or s.c. until an improvement is observed. For influenza, mixed injections (1 ampule i.m., possibly with the patient's own blood) together with Gripp-Heel (possibly 2 ampules) and Traumeel.
For the stimulation of the nonspecific defense system in viral infection such as:
Active Ingredients: Each 300 mg contains: Asclepias vincetoxicum 6X, 10X, 30X, 75mg each; Sulphur 4X 10X 37.5 mg each. Inactive ingredients: Lactose, Magnesium stearate. (1X=1:10 dilution, 2X=1:100, 3X=1:1000 etc).
Inactive Ingredients: Magnesium stearate USP, Lactose USP